post-cardiac arrest care
After ROSC the injury continues: brain (hypoxic–ischaemic), heart (stunning), whole-body reperfusion, plus whatever caused the arrest. ECG now — STEMI → cath lab even if comatose; no ST elevation → delayed angiography unless shock, recurrent VT/VF or ongoing ischaemia. Then protect the brain: MAP ≥65, normoxia, normocapnia, glucose control, prevent fever (≤37.5 °C for ≥72 h), EEG for seizures. No prognosis before 72 h after normothermia with sedation off, and never from one test.
post-ROSC ICU bundle
- ST elevation with suspected cardiac cause → emergency angiography, even if comatose
- no ST elevation: emergency angiography only for shock, recurrent VT/VF or ongoing ischaemia; otherwise before discharge if cardiac cause
- echo; CT head (± chest/abdomen/pelvis) if cause unclear or CPR trauma suspected
- arterial line; MAP ≥65 mmHg (norepinephrine ± inotrope)
- SpO₂ 90–98% (ERC: 94–98%; avoid hyperoxaemia); PaCO₂ 35–45 mmHg; Vt 6–8 mL/kg
- not following commands: core temp ≤37.5 °C ≥72 h (AHA 32–37.5 °C ≥36 h); rewarm ≤0.5 °C/h
- glucose 4–10 mmol/L
- not following commands: early EEG; treat clinical and EEG seizures; no seizure prophylaxis
- no prophylactic antibiotics
- sedation minimised for neuro exam (titrate to ventilator synchrony and shivering)
- no neuroprognosis <72 h after normothermia with sedation cleared; multimodal only
- early family meeting on the timeline of uncertainty
- survivors: cause work-up, ICD assessment, driving restrictions, cardiac rehab
post-cardiac arrest syndrome
- brain injury: cerebral oedema, impaired autoregulation (needs adequate MAP), seizures; hyperthermia, hypoxaemia, hyperoxaemia, hypocapnia and hypoglycaemia all worsen secondary injury
- myocardial dysfunction: global stunning, worst at 24–72 h, usually recovers → may need inotrope early; doesn’t by itself prove ACS
- systemic ischaemia–reperfusion: vasoplegia, capillary leak, coagulopathy, AKI — looks like sepsis
- precipitating cause: ACS, primary arrhythmia, PE, hypoxaemia, haemorrhage, electrolytes, toxins → find and treat
coronary angiography
| situation | timing |
|---|---|
| ST elevation (suspected cardiac cause), comatose or not | emergent primary PCI; fibrinolysis if timely PCI unavailable |
| no ST elevation + shock, recurrent VT/VF or ongoing ischaemia | emergent (AHA 2a) |
| no ST elevation, comatose, stable | delayed or selective — no benefit from immediate angiography (COACT (2019), TOMAHAWK (2021)) |
| survivor with suspected cardiac cause (esp. shockable rhythm, unexplained LV dysfunction) | before discharge (AHA I) |
- start temperature control alongside angiography, not after
- STEMI after arrest → STEMI management; shock after ROSC → cardiogenic shock (routine MCS not recommended)
- comatose STEMI with features predicting poor neurological outcome (unwitnessed, no bystander CPR, non-shockable, prolonged ROSC time, severe acidosis/lactate) → individualise
haemodynamics, oxygen and ventilation
- MAP ≥65 mmHg (AHA I; CCS); higher targets no better — BOX (2022): MAP 77 vs 63 mmHg → same death or severe disability
- vasopressor of choice: norepinephrine; add inotrope for low output → vasoactive drugs
- oxygen: 100% until measured, then SpO₂ 90–98% (AHA: PaO₂ 60–105; CCS: 68–105, avoid <68 and >195 mmHg; ERC: SpO₂ 94–98%, PaO₂ 75–100); pulse oximetry can hide hypoxaemia in darker skin
- PaCO₂ 35–45 mmHg — hypocapnia → cerebral vasoconstriction; check ABG, not just ETCO₂. Lung-protective Vt 6–8 mL/kg (ERC)
temperature control
- all patients not following commands after ROSC, any rhythm, in or out of hospital
- target: ERC-ESICM 2025 — prevent fever, ≤37.5 °C for ≥72 h; CCS 2024 — “reasonable” to target ≤37.5 °C and continue temperature control ≥72 h (its strong rec for 33–36 °C applies if hypothermic TTM is chosen); AHA 2025 — any temperature 32–37.5 °C, for ≥36 h (AHA I / 2a)
- TTM2 (2021): n=1900, 33 °C vs normothermia (≤37.5 °C, active cooling at ≥37.8 °C) for 40 h → 6-month death 50.3% vs 48.2%, no difference in poor function; more haemodynamically significant arrhythmia with 33 °C (23.9% vs 16.5%) → fever prevention is the goal
- start in hospital; prehospital cold IV fluids not recommended (pulmonary oedema, re-arrest)
- continuous core temperature monitoring; surface or intravascular devices perform similarly (intravascular: more bleeding in one RCT); treat shivering
- avoiding rewarming faster than 0.5 °C/h may be reasonable (AHA 2b)
- uncertain whether sicker subgroups do better with hypothermia
- spontaneous mild hypothermia (32–36 °C) after ROSC: don’t actively rewarm (ERC)
seizures, other treatments
- EEG promptly and repeatedly/continuously in patients not following commands; nonconvulsive seizures common
- treat clinical seizures and EEG-only seizures: levetiracetam or valproate first line plus sedation (ERC); no seizure prophylaxis; trial of a non-sedating drug for ictal–interictal patterns may be reasonable
- generalized periodic discharges alone → unlikely to benefit from suppression (CCS); no seizure prophylaxis
- antibiotics: no routine prophylaxis (AHA: uncertain benefit; CCS: reserve for suspected pneumonia)
- steroids for post-arrest shock: uncertain; no proven neuroprotective drug
- glucose: avoid <3.9 and >10 mmol/L
neuroprognostication
Most deaths after ROSC follow withdrawal of life-sustaining measures for a presumed poor neurological prognosis, so a false-positive prediction is the error that matters. Hence: wait, exclude confounders, and require agreement across modalities.
- no definitive prediction in the first 24 h (CCS 2023, strong). Formal assessment at ≥72 h after ROSC in anyone not obeying commands (ERC-ESICM 2025), once sedation, NMBA, hypothermia and metabolic or organ-failure confounders are excluded. Delay further if confounded or if seizures are still being treated
- withdrawal of life-sustaining measures needs adverse findings in ≥2 modalities (CCS 2023, strong; ERC-ESICM: ≥2 predictors)
| modality | predicts poor outcome | caveat |
|---|---|---|
| exam | bilaterally absent pupillary reflexes at ≥72 h (CCS strong); absent corneals at ≥72 h (weaker); quantitative pupillometry from ≥48 h (weak, thresholds unclear) | motor M1–2 alone is not poor prognosis (high false-positive rate); motor score is an entry criterion only |
| myoclonus | status myoclonus within 72 h (ERC) / first 7 days (CCS), only combined with other findings | get an EEG: some myoclonus (Lance-Adams, reactive background) is compatible with recovery |
| EEG | highly malignant patterns after 24 h (ERC; CCS weak, suppressed background only ≥72 h): suppressed background ± periodic discharges, burst suppression (AHA: burst suppression off sedation at ≥72 h) | electrographic status epilepticus alone is not definitive → treat it, delay prognostication. Don’t use absent EEG reactivity |
| SSEP | bilaterally absent N20 (from ≥24 h CCS/ERC; AHA ≥48 h) | needs a comatose patient (no purposeful pain response); NMBA reduces artefact |
| imaging | CT within 72 h: low grey–white ratio (quantitative, e.g. <1.15–1.20); MRI within 7 days if still uncertain: extensive diffusion restriction | repeat CT at 72–96 h if the first one was early and normal |
| biomarkers | NSE >60 µg/L at 48 and/or 72 h, or a rising trend (ERC-ESICM) | CCS: not routinely (assay and threshold variability). Neurofilament light: not yet (ERC-ESICM); AHA 2025: high NSE or NfL within 72 h may be considered (2b) |
- normal SSEPs, a continuous reactive EEG or low NSE favour recovery and argue for more time
- an indeterminate picture at 72 h → keep supporting and reassess; late awakening happens
- regular, early, transparent family discussions about the timeline and the uncertainty
- not the same as death determination → death determination and organ donation (prerequisites, 48 h rule after ROSC)
refractory arrest (persisting VF/pVT)
- amiodarone or lidocaine after ≥1 failed shock, particularly witnessed arrest
- after ≥3 failed shocks: double sequential or vector-change defibrillation if equipment and training available
- eCPR (VA-ECMO): not routine; selected patients — witnessed arrest, limited comorbidity, refractory >5–15 min, arrest-to-cannulation <60 min and hospital arrival-to-cannulation <30 min, at centres with an established pathway (CCS)
after survival
- arrest cause and secondary prevention: ICD for VF/VT arrest without a reversible cause → ventricular arrhythmias and sudden cardiac death
- driving → fitness to drive (cardiac)
- cognitive, mood and fatigue screening before discharge; rehabilitation
Prepared 2026-10-29. Not yet verified — check every number against the sources.